Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
|Articles|July 23, 2010
- The Column-07-23-2010
- Volume 6
- Issue 13
Market Profile: High Content Screening
High content screening (HCS) is a high-throughput method, which enables the functional analysis of cells. HCS plays a vital role for drug discovery applications, including drug targets verification and pathway detection, in both the pharmaceutical and biotechnology industries.
Advertisement
High content screening (HCS) is a high-throughput method, which enables the functional analysis of cells. HCS plays a vital role for drug discovery applications, including drug targets verification and pathway detection, in both the pharmaceutical and biotechnology industries. The technology is often used in neuroscience research, especially in drug development for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases.
Articles in this issue
over 16 years ago
GCxGC Symposiumover 16 years ago
Climate of Innovationover 16 years ago
Thought Leaderover 16 years ago
The art of chromatographyover 16 years ago
Musings from the Little Black Book of GC (Part 2)over 16 years ago
Peak Integration that Matches the Efficiency Principles of UHPLCAdvertisement
Related to this article
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Sam Whitmarsh explores how retention-time models handle interlaboratory data, novel chemotypes, unusual phases and ionisable compounds, and what labs need to do to build useful in-house models.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
2
LCGC Blog: Building a Career Series That Goes Beyond the Surface
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5